ABL Bio secures FDA Fast Track for gastric cancer therapy

ABL Bio said Wednesday that the US Food and Drug Administration granted Fast Track designation to Givastomig (ABL111), its gastric cancer treatment candidate be

Raccontata dakoreaherald.com